You have likely heard the common phrase: “Depression is just a chemical imbalance in the brain.”
For decades, medical professionals, social media, television, and movies repeated this exact explanation. Many of us can even name the specific chemical involved: serotonin. Because of this widespread belief, millions of people recognize major selective serotonin reuptake inhibitors (SSRIs) like Lexapro, Celexa, Prozac, and Zoloft.
However, recent clinical research completely challenges this oversimplified narrative, exposing the widespread chemical imbalance myth. While this old explanation is commonly circulated and accepted as absolute truth, it fails to show the whole picture. If a simple chemical shortage does not cause depression and anxiety, what actually does?
The Serotonin Theory
The notion that a lack of serotonin causes depression originated in the 1950s and 1960s with the rise of tricyclic antidepressant medications. Because these medications increased serotonin in the brain, researchers and doctors used simplistic reductionism to draw a conclusion. They assumed that if successful depression medications raised serotonin, then a lack of serotonin must cause the disease.
Unfortunately, the true origin of mental health conditions is rarely that simple. This theory, however, did help to destigmatize mental illness. It placed the cause of depression on biology and chemistry instead of personal fault.
Despite the flaws behind this narrative, drug companies developed SSRIs based on this model. Serotonin acts as a chemical messenger in the brain, influencing mood, emotions, and sleep cycles. Once the brain uses serotonin, nerve cells reabsorb it through a process called “reuptake.” SSRIs block this reabsorption, leaving more active serotonin available in the brain.
Clinical data shows mixed results for this approach. A 2020 study found that antidepressants improved symptoms in 40 to 60 out of 100 people after six to eight weeks of consistent use. However, these medications rarely eliminate symptoms entirely. Patients also frequently report side effects. These include insomnia, headaches, gastrointestinal distress, dry mouth, dizziness, decreased libido, and even increased suicidal thoughts in rare cases.
Relying entirely on these medications keeps patients trapped in the chemical imbalance myth, ignoring the deeper systemic roots of their symptoms.
Evidence Against the Serotonin Theory
While SSRIs offer some effectiveness, a critical question remains: do they work because they increase serotonin, or is another mechanism at play? Significant evidence continues to challenge the traditional serotonin model.
1. Receptor Activity
Serotonin binds to 14 different receptors, but researchers focus most of their studies on just one: the 5-HT(1a) receptor. These receptors inhibit the pre-synaptic release of serotonin across synapses, which are the spaces where neurons transmit information.
If low serotonin caused depression, these receptors would theoretically show much higher activity to keep serotonin levels down. However, clinical research shows no difference in 5-HT(1a) receptor activity between patients with depression and healthy controls.
2. Transporter Protein Data
Serotonin transporter proteins (SERT) remove serotonin from the synapse, lowering its availability in the brain. If depression stems from a problem with these transporters, we would expect higher SERT activity in depressed patients.
The data does not support this theory. While scientists need to conduct more research, the current findings fail to connect SERT malfunctions to depression. Additionally, many study participants previously used SSRIs, which could alter brain circuitry and skew the historical data.
3. Tryptophan Depletion Studies
The body naturally converts the amino acid tryptophan into serotonin. Therefore, a lack of dietary tryptophan should result in lower serotonin levels.
To test this, researchers conducted tryptophan depletion studies by depriving participants of this essential amino acid. Surprisingly, the acute drop in serotonin had no negative impact on the participants’ moods compared to the control group.
While the medical community requires more well-designed studies, the current evidence is clear. A simple lack of serotonin does not cause depression. Relying on this outdated explanation only perpetuates the chemical imbalance myth, slowing down our understanding of true biological healing.
Depression, the Limbic System, and the Brain
The limbic system of the brain is involved in behavior, memory, and emotional responses. Patients with depression have pathologies of the limbic system and physical changes in the brain. There is a loss of synaptic activity, which is associated with a decrease in brain derived neurotrophic factor (BDNF). BDNF helps the brain create new connections, repairs failing brain cells, and protects existing brain cells. It is important for learning, memory, and protection against neurodegenerative diseases. There is a decrease in overall metabolic activity and a reduction in the size of the prefrontal cortex, the area of the brain responsible for cognitive control such as reasoning, problem solving, impulse-control, creativity, and critical thinking.
Earlier we mentioned that SSRIs were somewhat effective in treating depression, even if serotonin may not be the cause, or full cause, of the disease. Why is that? It has been shown that the increase in serotonin may promote positive changes to the limbic system itself. When the system is flooded with serotonin, the changes within the limbic system help treat the symptoms of depression, but are not a cure, nor does it prevent a relapse from occurring.
Therapy can cause similar changes to the limbic system, and these changes may be more permanent than medications. The “catch” however, is that therapy can take much longer than medications. Patients may start to see some improvement in symptoms within 2-4 weeks of starting a medication. One study found that it took 6 months of weekly therapy (21 sessions) to see a clinically significant response in about 50% of the patients. It can take anywhere from 52-75 sessions to see clinical success with therapy. Many patients opt to use mediation and talk therapy- medications work much quicker, but the therapy may produce longer lasting changes, so they complement each other well.
Depression and the Immune System
An emerging area of research is focused on examining the link between the immune system and depression. The immune system is a complex system within the body that protects and fights against diseases. We know that dysregulation within the immune system can cause and promote a variety of diseases and mental illness, such as depression, may be one of them.
Immune cells within the central nervous system (CNS) are called microglia, and they make up 5-10% of all brain cells. Their main function is to promote homeostasis, a state of equilibrium and balance, within the CNS. They play a role in synapse pruning (eliminating old, unused synapses) and neurogenesis (formation of new neurons).
Microglia can produce cytokines. Cytokines are a variety of proteins that stimulate or sometimes slow down the immune system. Some, but not all, are inflammatory. Low activity levels of inflammatory cytokines in the brain is actually a good thing, as it helps promote neuroplasticity. Neuroplasticity is important because it helps the brain modify, change, and adapt to needs. Excessive inflammatory immune activation in the brain disrupts neuronal function by impairing neurotransmitter communication, disrupting the synthesis/ reuptake/ release of neurotransmitters, and impacting neurocircuit functions, including mood and cognition. Both physical and psychological stress has been known to increase cytokine activity in the brain, past healthy levels.
Some patients with depression have increased immune activity, but not all depressed patients present with increased inflammation, as measured by various inflammatory markers in the blood. More research is needed to determine why some patients have increased immune activity, and if this activity is casual or not.
Chronic Stress and Depression
Stress plays a major role in the daily lives of most Americans. We live in a culture that is focused on productivity and efficiency, usually at the expense of relaxation and well-being. Stress isn’t solely a psychological phenomenon- it has real, measurable impacts on our brain. It can decrease neurogenesis and dendrite complexity. Stress causes hypertrophy, or an enlargement, in the nucleus accumbens (responsible for motivation) and amygdala (responsible for fear). It also decreases BDNF in the prefrontal cortex and hippocampus. Remember, BDNF is a protein that is important in brain health. Chronic stress plays a major role in epigenetic modifications to depression. Epigenetics is a term used to describe the way behaviors and environments impact gene expression. It can promote depression and even produce a resistance to antidepressants. Mature coping mechanisms and resiliency are protective against depression.
What Works for Depression?
As mental health issues become more prevalent, researchers must continue investigating the true underlying causes of emotional distress. While we now know that serotonin levels alone do not cause depression, effective treatments still exist.
Even though SSRIs may not work exactly how scientists initially believed, these medications still help improve symptoms for many individuals. Talk therapy provides incredible results, especially when patients couple it with proper medical management. This combination can even create permanent, positive changes in brain structure.
Nutrition also plays a massive role in recovery. Adopting a nutrient-dense Mediterranean diet actively increases dendrite complexity, synaptic density, and brain-derived neurotrophic factor (BDNF). This nutritional shift effectively reverses some of the physical brain changes that chronic depression causes. Furthermore, recent clinical studies prove that regular exercise can be just as effective as traditional antidepressants for treating major depressive disorder.
If you currently take antidepressant medications, you must never abruptly stop using them, even if you feel they are not working. Always discuss your health concerns directly with your healthcare provider. Your provider can design a safe, gradual taper to help you avoid uncomfortable withdrawal symptoms before you transition to any new alternative treatments.
Moving Beyond the Chemical Imbalance Myth
Understanding the complex nature of mental health allows us to look far past the traditional chemical imbalance myth. Depression and anxiety are rarely individual brain failures. Instead, they represent systemic warnings from a body experiencing chronic inflammation, metabolic distress, or untreated trauma.
At Modyfi Health, we do not patch over your symptoms with a one-size-fits-all prescription. Our virtual network of board-certified psychiatrists, specialized therapists, and clinical nutritionists works as a synchronized team. Through our comprehensive Root-Cause Psychiatry approach, we analyze your entire biology—investigating hormone balance, nutrient deficiencies, and gut health—to design a personalized treatment plan that brings lasting healing.
Our multidisciplinary methods follow rigorous clinical evidence. Research published and supported by global institutions like the National Institutes of Health (NIH) and the American Psychiatric Association highlights the deep connection between systemic physical health and mental well-being.
You deserve a mental health care plan that looks at the big picture. Let us help you discover what your body actually needs to thrive.
👉 Click here to schedule your FREE Discovery Call with Modyfi Health
Sources:
Beurel, E., Toups, M., & Nemeroff, C. B. (2020). The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron, 107(2), 234–256. https://doi.org/10.1016/j.neuron.2020.06.002
InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Depression: How effective are antidepressants? [Updated 2020 Jun 18]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK361016/
Misaghi A. , Page K., Puder D. (Hosts).(2022). Is depression a chemical imbalance? (No. 155). [Audio podcast episode] In Psychiatry & Psychotherapy. https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-155-is-depression-a-chemical-imbalance
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A Systematic Umbrella Review of the evidence. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01661-0
